Viatris (LTS:0A5V) Cash From Other Investing Activities : $226 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Viatris Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Viatris's cash from other investing activities for the three months ended in Mar. 2024 was $191 Mil. It means Viatris received $191 Mil from other investing activities. Viatris's cash from other investing activities for the trailing twelve months (TTM) ended in Mar. 2024 was $226 Mil.

Viatris Cash From Other Investing Activities Historical Data

The historical data trend for Viatris's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Cash From Other Investing Activities Chart

Viatris Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Other Investing Activities

Get a 7-Day Free Trial

220.80

-223.00

-83.50

1,544.00

-680.60

Viatris Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash From Other Investing Activities	Get a 7-Day Free Trial															-47.80	-67.80	-47.90	150.60	190.80

Viatris Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $226 Mil.

Viatris Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of Viatris's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Viatris (LTS:0A5V) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (LTS:0A5V) » Definitions » Cash From Other Investing Activities

Comparable Companies

Traded in Other Exchanges

VTRS:USA MYL:Mexico 1VTRS:Italy VIA:Germany MYL:Austria

Address

1000 Mylan Boulevard, Canonsburg, PA, USA, 15317

Website

https://www.viatris.com

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Viatris (LTS:0A5V) Headlines

No Headlines